195 related articles for article (PubMed ID: 35726011)
1. The application prospects of honokiol in dermatology.
Li Y; Liang C; Zhou X
Dermatol Ther; 2022 Aug; 35(8):e15658. PubMed ID: 35726011
[TBL] [Abstract][Full Text] [Related]
2. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.
Shen JL; Man KM; Huang PH; Chen WC; Chen DC; Cheng YW; Liu PL; Chou MC; Chen YH
Molecules; 2010 Sep; 15(9):6452-65. PubMed ID: 20877235
[TBL] [Abstract][Full Text] [Related]
3. Isolation of anti-Saprolegnia lignans from Magnolia officinalis and SAR evaluation of honokiol/magnolol analogs.
Hu Y; Shen Y; Tu X; Wu X; Wang GX; Ling F
Bioorg Med Chem Lett; 2019 Feb; 29(3):389-395. PubMed ID: 30579792
[TBL] [Abstract][Full Text] [Related]
4. Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review.
Pan C; Li Q; Xiong S; Yang Y; Yang Y; Huang C; Wang ZP
Chem Biodivers; 2024 Jun; 21(6):e202302032. PubMed ID: 38308434
[TBL] [Abstract][Full Text] [Related]
5. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
Vaid M; Sharma SD; Katiyar SK
Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
[TBL] [Abstract][Full Text] [Related]
6. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.
Chan SS; Zhao M; Lao L; Fong HH; Che CT
Planta Med; 2008 Mar; 74(4):381-4. PubMed ID: 18484527
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Modulating Effects of Magnolol and Honokiol, Two Polyphenolic Compounds from Traditional Chinese Medicine-Magnolia Officinalis.
Yuan Y; Zhou X; Wang Y; Wang Y; Teng X; Wang S
Curr Drug Targets; 2020; 21(6):559-572. PubMed ID: 31749425
[TBL] [Abstract][Full Text] [Related]
8. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology-based method to explore the therapeutic effect of honokiol on diabetes with comorbid depression in mice.
Sun H; Liu Y; Wang X; Shu L
Eur J Pharmacol; 2024 Jul; 975():176642. PubMed ID: 38754538
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.
Lee J; Jung E; Park J; Jung K; Lee S; Hong S; Park J; Park E; Kim J; Park S; Park D
Planta Med; 2005 Apr; 71(4):338-43. PubMed ID: 15856410
[TBL] [Abstract][Full Text] [Related]
11. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
Yamaguchi M; Arbiser JL; Weitzmann MN
Int J Mol Med; 2011 Dec; 28(6):1049-53. PubMed ID: 21887456
[TBL] [Abstract][Full Text] [Related]
12. Antifungal Effect of Magnolol and Honokiol from
Chen YH; Lu MH; Guo DS; Zhai YY; Miao D; Yue JY; Yuan CH; Zhao MM; An DR
Molecules; 2019 Jun; 24(11):. PubMed ID: 31174300
[TBL] [Abstract][Full Text] [Related]
13. Honokiol and magnolol: A review of structure-activity relationships of their derivatives.
Dai SY; Qin WX; Yu S; Li C; Yang YH; Pei YH
Phytochemistry; 2024 Jul; 223():114132. PubMed ID: 38714288
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of honokiol：pharmacological activities, manmade derivatives and structure-activity relationship.
Li X; Yuan Z; Wang Y; Wang W; Shi J
Eur J Med Chem; 2024 Jun; 272():116471. PubMed ID: 38704945
[TBL] [Abstract][Full Text] [Related]
15. Research Progress on the Structural Modification of Magnolol and Honokiol and the Biological Activities of Their Derivatives.
Ming-Xin Guo MM; Wu X; Feng YF; Hu ZQ
Chem Biodivers; 2023 Aug; 20(8):e202300754. PubMed ID: 37401658
[TBL] [Abstract][Full Text] [Related]
16. Maximizing dermal targeting and minimizing transdermal penetration by magnolol/honokiol methoxylation.
Lin CF; Hwang TL; Al-Suwayeh SA; Huang YL; Hung YY; Fang JY
Int J Pharm; 2013 Mar; 445(1-2):153-62. PubMed ID: 23380623
[TBL] [Abstract][Full Text] [Related]
17. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.
Prasad R; Katiyar SK
Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820
[TBL] [Abstract][Full Text] [Related]
18. Magnolol and honokiol from Magnolia officinalis enhanced antiviral immune responses against grass carp reovirus in Ctenopharyngodon idella kidney cells.
Chen X; Hu Y; Shan L; Yu X; Hao K; Wang GX
Fish Shellfish Immunol; 2017 Apr; 63():245-254. PubMed ID: 28232195
[TBL] [Abstract][Full Text] [Related]
19. Honokiol suppresses 2,6-dinitrochlorobenzene-induced atopic dermatitis in mice.
Lee JH; Im DS
J Ethnopharmacol; 2022 May; 289():115023. PubMed ID: 35074454
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Either C2- or C4'-Alkylated Derivatives of Honokiol and Their Biological Evaluation for Anti-inflammatory Activity.
Lee SH; Fei X; Lee C; Do HTT; Rhee I; Seo SY
Chem Pharm Bull (Tokyo); 2019 Sep; 67(9):966-976. PubMed ID: 31257308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
